Global Meningococcal Conjugate Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Meningococcal Conjugate Revenue
• 1.4 Market by Type
  • 1.4.1 Global Meningococcal Conjugate Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Menactra
  • 1.4.3 Menveo
  • 1.4.4 NeisVac-C
  • 1.4.5 Nimenrix
  • 1.4.6 Others
• 1.5 Market by Application
  • 1.5.1 Global Meningococcal Conjugate Market Share by Application: 2020 VS 2026
  • 1.5.2 Children
  • 1.5.3 Preteens or Teens
  • 1.5.4 Adults
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Meningococcal Conjugate Market Perspective (2015-2026)
• 2.2 Global Meningococcal Conjugate Growth Trends by Regions
  • 2.2.1 Meningococcal Conjugate Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Meningococcal Conjugate Historic Market Share by Regions (2015-2020)
  • 2.2.3 Meningococcal Conjugate Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Meningococcal Conjugate Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Meningococcal Conjugate Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Meningococcal Conjugate Players by Market Size
  • 3.1.1 Global Top Meningococcal Conjugate Players by Revenue (2015-2020)
  • 3.1.2 Global Meningococcal Conjugate Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Meningococcal Conjugate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Meningococcal Conjugate Market Concentration Ratio
  • 3.2.1 Global Meningococcal Conjugate Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Meningococcal Conjugate Revenue in 2019
• 3.3 Meningococcal Conjugate Key Players Head office and Area Served
• 3.4 Key Players Meningococcal Conjugate Product Solution and Service
• 3.5 Date of Enter into Meningococcal Conjugate Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Meningococcal Conjugate Historic Market Size by Type (2015-2020)
• 4.2 Global Meningococcal Conjugate Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Meningococcal Conjugate Market Size by Application (2015-2020)
• 5.2 Global Meningococcal Conjugate Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Meningococcal Conjugate Market Size (2015-2020)
• 6.2 Meningococcal Conjugate Key Players in North America (2019-2020)
• 6.3 North America Meningococcal Conjugate Market Size by Type (2015-2020)
• 6.4 North America Meningococcal Conjugate Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Meningococcal Conjugate Market Size (2015-2020)
• 7.2 Meningococcal Conjugate Key Players in Europe (2019-2020)
• 7.3 Europe Meningococcal Conjugate Market Size by Type (2015-2020)
• 7.4 Europe Meningococcal Conjugate Market Size by Application (2015-2020)

8 China

• 8.1 China Meningococcal Conjugate Market Size (2015-2020)
• 8.2 Meningococcal Conjugate Key Players in China (2019-2020)
• 8.3 China Meningococcal Conjugate Market Size by Type (2015-2020)
• 8.4 China Meningococcal Conjugate Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Meningococcal Conjugate Market Size (2015-2020)
• 9.2 Meningococcal Conjugate Key Players in Japan (2019-2020)
• 9.3 Japan Meningococcal Conjugate Market Size by Type (2015-2020)
• 9.4 Japan Meningococcal Conjugate Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Meningococcal Conjugate Market Size (2015-2020)
• 10.2 Meningococcal Conjugate Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Meningococcal Conjugate Market Size by Type (2015-2020)
• 10.4 Southeast Asia Meningococcal Conjugate Market Size by Application (2015-2020)

11 India

• 11.1 India Meningococcal Conjugate Market Size (2015-2020)
• 11.2 Meningococcal Conjugate Key Players in India (2019-2020)
• 11.3 India Meningococcal Conjugate Market Size by Type (2015-2020)
• 11.4 India Meningococcal Conjugate Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Meningococcal Conjugate Market Size (2015-2020)
• 12.2 Meningococcal Conjugate Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Meningococcal Conjugate Market Size by Type (2015-2020)
• 12.4 Central & South America Meningococcal Conjugate Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Sanofi Pasteur
  • 13.1.1 Sanofi Pasteur Company Details
  • 13.1.2 Sanofi Pasteur Business Overview
  • 13.1.3 Sanofi Pasteur Meningococcal Conjugate Introduction
  • 13.1.4 Sanofi Pasteur Revenue in Meningococcal Conjugate Business (2015-2020))
  • 13.1.5 Sanofi Pasteur Recent Development
• 13.2 Pfizer
  • 13.2.1 Pfizer Company Details
  • 13.2.2 Pfizer Business Overview
  • 13.2.3 Pfizer Meningococcal Conjugate Introduction
  • 13.2.4 Pfizer Revenue in Meningococcal Conjugate Business (2015-2020)
  • 13.2.5 Pfizer Recent Development
• 13.3 Glaxo Smith Kline
  • 13.3.1 Glaxo Smith Kline Company Details
  • 13.3.2 Glaxo Smith Kline Business Overview
  • 13.3.3 Glaxo Smith Kline Meningococcal Conjugate Introduction
  • 13.3.4 Glaxo Smith Kline Revenue in Meningococcal Conjugate Business (2015-2020)
  • 13.3.5 Glaxo Smith Kline Recent Development
• 13.4 Hualan Biological Engineering
  • 13.4.1 Hualan Biological Engineering Company Details
  • 13.4.2 Hualan Biological Engineering Business Overview
  • 13.4.3 Hualan Biological Engineering Meningococcal Conjugate Introduction
  • 13.4.4 Hualan Biological Engineering Revenue in Meningococcal Conjugate Business (2015-2020)
  • 13.4.5 Hualan Biological Engineering Recent Development
• 13.5 JN International Medical Corporation
  • 13.5.1 JN International Medical Corporation Company Details
  • 13.5.2 JN International Medical Corporation Business Overview
  • 13.5.3 JN International Medical Corporation Meningococcal Conjugate Introduction
  • 13.5.4 JN International Medical Corporation Revenue in Meningococcal Conjugate Business (2015-2020)
  • 13.5.5 JN International Medical Corporation Recent Development
• 13.6 Baxter International
  • 13.6.1 Baxter International Company Details
  • 13.6.2 Baxter International Business Overview
  • 13.6.3 Baxter International Meningococcal Conjugate Introduction
  • 13.6.4 Baxter International Revenue in Meningococcal Conjugate Business (2015-2020)
  • 13.6.5 Baxter International Recent Development
• 13.7 Merck
  • 13.7.1 Merck Company Details
  • 13.7.2 Merck Business Overview
  • 13.7.3 Merck Meningococcal Conjugate Introduction
  • 13.7.4 Merck Revenue in Meningococcal Conjugate Business (2015-2020)
  • 13.7.5 Merck Recent Development
• 13.8 Serum Institute of India
  • 13.8.1 Serum Institute of India Company Details
  • 13.8.2 Serum Institute of India Business Overview
  • 13.8.3 Serum Institute of India Meningococcal Conjugate Introduction
  • 13.8.4 Serum Institute of India Revenue in Meningococcal Conjugate Business (2015-2020)
  • 13.8.5 Serum Institute of India Recent Development
• 13.9 Biomed
  • 13.9.1 Biomed Company Details
  • 13.9.2 Biomed Business Overview
  • 13.9.3 Biomed Meningococcal Conjugate Introduction
  • 13.9.4 Biomed Revenue in Meningococcal Conjugate Business (2015-2020)
  • 13.9.5 Biomed Recent Development
• 13.10 Novartis
  • 13.10.1 Novartis Company Details
  • 13.10.2 Novartis Business Overview
  • 13.10.3 Novartis Meningococcal Conjugate Introduction
  • 13.10.4 Novartis Revenue in Meningococcal Conjugate Business (2015-2020)
  • 13.10.5 Novartis Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer